Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
English
Deutsch
Home
Profiles
Research units
Projects
Research output
Datasets
Prizes
Activities
Press/Media
Impacts
Search by expertise, name or affiliation
STELLENWERT IMMUNSUPPRESSIV WIRKENDER PHARMAKA IN DER ANTIPSORIATISCHEN THERAPIE
Translated title of the contribution
:
Evaluation of immunosuppressive acting antipsoriatic agents
R. Engst
,
S. Borelli
Default
Department of Dermatology and Allergology
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Evaluation of immunosuppressive acting antipsoriatic agents'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Kidney Function
100%
Psoriasis
100%
Laboratory Control
100%
Dose Finding
100%
Corticoids
100%
Antipsoriatic
100%
Potential Risk
50%
Severe Cases
50%
Liver
50%
Bone Marrow
50%
Severe Course
50%
Normal Liver
50%
Scalp
50%
Methotrexate
50%
Cyclosporine
50%
Psoriasis Treatment
50%
Plaque-type Psoriasis
50%
Pustular Psoriasis
50%
Erythrodermic Psoriasis
50%
Medicine and Dentistry
Kidney Function
100%
Side Effect
100%
Psoriasis
100%
Antipsoriatic
100%
Pustular Psoriasis
100%
Immunosuppressive Drug
100%
Corticosteroid
100%
Cyclosporine
50%
Scalp
50%
Rebound
50%
Erythrodermic Psoriasis
50%
Methotrexate
50%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsoriasis Agent
100%
Side Effect
100%
Immunosuppressive Agent
100%
Pustular Psoriasis
100%
Psoriasis
100%
Corticosteroid
100%
Erythrodermic Psoriasis
50%
Methotrexate
50%
Ciclosporin
50%